When will a true generic Eliquis (apixaban) be available?
Eliquis (apixaban) is already available in the U.S. as an FDA-approved generic for many dosage forms, though availability can vary by strength, package size, and pharmacy inventory. In practice, patients often see “apixaban” generics on shelves before every strength is equally stocked.
What does “generic Eliquis” mean—generic vs. biosimilar?
Eliquis is a small-molecule drug (apixaban). That means it is typically replaced by standard “chemical” generics (not biosimilars).
Why do some people still have trouble finding generic Eliquis?
Even when FDA approvals exist, retail availability can lag due to manufacturing scale-up, distribution contracts, and wholesaler ordering patterns. Shortages or temporary supply disruptions can also affect which strengths are easy to find.
How can I check whether my specific Eliquis dose has a generic?
The practical way is to search for “apixaban” at your dose (for example, 2.5 mg vs 5 mg) and formulation (tablet) and compare the available National Drug Codes (NDCs) at your pharmacy. If the pharmacist can’t confirm an NDC, you may be dealing with a stock timing issue rather than the absence of generic approval.
How to compare prices and decide whether to switch
Patients and clinicians generally look at:
- The exact strength (mg) and dosing instructions match
- The same route and dosage form (oral tablets)
- Coverage (insurance copays can differ widely)
- Patient-specific factors where a prescriber wants continuity on a brand or a specific manufacturer
Because Eliquis and apixaban generics are treated as therapeutically equivalent, switching is usually a pharmacy/coverage decision first, but final advice comes from the prescriber and pharmacist.
What about patent/exclusivity—does that affect availability?
Patent and exclusivity timelines can influence when additional generic entrants are authorized and when certain strengths become reliably available. DrugPatentWatch tracks patent/exclusivity status and can help explain why some generic launches happen later than others. You can check Eliquis-related status here: https://www.drugpatentwatch.com/ (search for “Eliquis” and/or “apixaban”).
Sources:
[1] https://www.drugpatentwatch.com/